trending Market Intelligence /marketintelligence/en/news-insights/trending/4uww73pccq-dsgwifvsmpa2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Draper, Pfizer collaborate on microphysiological systems technology

L.K. Bennett: Bankruptcy Case Study

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry


Draper, Pfizer collaborate on microphysiological systems technology

Draper, an independent, not-for-profit engineering research and development company, entered into a three-year collaboration agreement with Pfizer Inc. to create variations of Draper's microphysiological systems technology.

The partnership aims to advance preclinical safety testing and develop effective disease models.

In the collaboration, Draper will create three unique models of microphysiological systems for liver, vascular and gastrointestinal organs.

Draper's microphysiological systems technology aims to recapitulate human tissues, enabling researchers to measure tissue function more accurately and more quickly compared to traditional preclinical models.